- Research works
- 57 ▼ 69% vs 2013–17
- Citations
- 3.5k 62.0 per fractional work
- Top-10% rate
- 17.0% record average 16.5%
- Open access
- 18% world 28%
Not ranked overall: Leuka is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Leuka?
By fractional works in all years, weighted toward what it does more of than the world: Prognostic Factors, Hematopoietic Stem Cells, BCR-ABL, Imatinib, Acute Myeloid Leukemia, AML, Rituximab and Chronic Lymphocytic Leukemia.
- FDG PET/CT
- PROTACs
- Genetic Pathogenesis
- BET Bromodomains
- Antimicrobial Agents
- PET Imaging
- Glycosylation
- Prophylaxis
- Piezo1
- Cancer Therapy
- Lymphoma
- Graft-versus-Host Disease
- Epigenetic Regulation
- Acute Lymphoblastic Leukemia
- Transcriptional Regulation
- Cancer
- Chronic Lymphocytic Leukemia
- Acute Myeloid Leukemia
- Imatinib
- Hematopoietic Stem Cells
- Prognostic Factors
- BCR-ABL
- AML
- Rituximab
- Genomic Aberrations
- Inflammation
- Minimal Residual Disease
- Childhood Cancer
- Bone Marrow Niche
- Classification
- Apoptosis
- Gene Expression
- Piezo2
- Arginine Methylation
- Hemostasis
- Protein Arginine Methyltransferases
- Febrile Neutropenia
- Gene Expression Regulation
- Molecular Profiling
- Bone Marrow Biopsy
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Prognostic Factors15▲ 58×4 topics
- Hematopoietic Stem Cells10▲ 174×3 topics
- BCR-ABL8▲ 478×1 topic
- Imatinib8▲ 478×1 topic
- AML7▲ 260×1 topic
- Acute Myeloid Leukemia7▲ 260×1 topic
- Rituximab7▲ 75×2 topics
- Chronic Lymphocytic Leukemia6▲ 203×1 topic
- Genomic Aberrations6▲ 203×1 topic
- Cancer5▲ 6.2×9 topics
- Inflammation3▲ 2.6×10 topics
- Transcriptional Regulation3▲ 19×3 topics
- Minimal Residual Disease2▲ 65×2 topics
- Acute Lymphoblastic Leukemia2▲ 114×1 topic
- Childhood Cancer2▲ 114×1 topic
- Epigenetic Regulation2▲ 20×4 topics
- Bone Marrow Niche2▲ 122×1 topic
- Graft-versus-Host Disease2▲ 122×1 topic
- Classification2▲ 11×2 topics
- Lymphoma2▲ 24×3 topics
- Apoptosis2▲ 8.5×3 topics
- Cancer Therapy2▲ 4.6×7 topics
- Gene Expression2▲ 5.0×4 topics
- Piezo12▲ 62×1 topic
- Piezo22▲ 62×1 topic
- Prophylaxis2▲ 18×2 topics
- Arginine Methylation1▲ 76×1 topic
- Glycosylation1▲ 11×2 topics
- Hemostasis1▲ 17×3 topics
- PET Imaging1▲ 11×2 topics
- Protein Arginine Methyltransferases1▲ 76×1 topic
- Antimicrobial Agents1▲ 129×1 topic
- Febrile Neutropenia1▲ 129×1 topic
- BET Bromodomains1▲ 107×1 topic
- Gene Expression Regulation1▲ 19×2 topics
- Genetic Pathogenesis1▲ 35×1 topic
- Molecular Profiling1▲ 18×1 topic
- PROTACs1▲ 107×1 topic
- Bone Marrow Biopsy1▲ 76×1 topic
- FDG PET/CT1▲ 64×1 topic
Which research topics does Leuka publish most on?
By volume in 2022–2025: Acute Myeloid Leukemia Research, Cutaneous lymphoproliferative disorders research, Lymphoma Diagnosis and Treatment and Immune cells in cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Acute Myeloid Leukemia Research Hematology 0 works
- 2 Cutaneous lymphoproliferative disorders research Dermatology 0 works
- 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 4 Immune cells in cancer Immunology 0 works
- 5 Hematological disorders and diagnostics Emergency Medicine 0 works
- 6 Childhood Cancer Survivors' Quality of Life Pediatrics, Perinatology and Child Health 0 works
- 7 Cancer Genomics and Diagnostics Cancer Research 0 works
- 8 Genomics and Chromatin Dynamics Molecular Biology 0 works
- 9 Epigenetics and DNA Methylation Molecular Biology 0 works
- 10 Hemoglobinopathies and Related Disorders Genetics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Leuka's research output changed?
Output in 2018–2022 was 69% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in London
- University College London
- Imperial College London
- King's College London
- Queen Mary University of London
- London School of Economics and Political Science
- University of London
- Brunel University of London
- London School of Hygiene & Tropical Medicine
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.